Asking for a Trend, anchor Josh Lipton breaks down the latest market moves for May 20, 2025. Trade worries and market uncertainty continue to linger.

OXLC's NAV has dropped sharply recently. Massive share issuance continued despite previous buyback announcements. The fund's high headline yield is unsustainable, with a likely distribution cut and potential reverse split looming due to declining NAV and payout coverage issues.

Tempus AI, Inc. is growing rapidly in healthcare tech, especially genomics, but is not yet profitable and carries significant risk. Recent revenue growth is boosted by the Ambry Genetics acquisition; organic growth remains strong, but future growth may slow post-acquisition. The company benefits from exposure to large, expanding markets and leverages AI/data partnerships, but faces high valuation multiples.

Market Domination anchors Julie Hyman and Josh Lipton break down the day's financial news for May 20, 2025. Alphabet's Google I/O developer conference kicked off today.

Ontrak, Inc. (NASDAQ:OTRK ) Q1 2025 Results Conference Call May 20, 2025 4:30 PM ET Company Participants Ryan Halsted - Investor Relations, Gilmartin Group Brandon LaVerne - Chief Executive Officer Mary Louise Osborne - President and Chief Commercial Officer James Park - Chief Financial Officer Operator Thank you for standing by, and welcome to the Ontrak Health's First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Waymo co-CEO Tekedra Mawakana told CNBC on Tuesday that the Alphabet-owned ride-hailing company has reached 10 million trips, doubling in the past five months. The Alphabet-owned company previously said it's doing over 250,000 paid trips per week.

Datavault AI Inc. (NASDAQ:DVLT ) Investor Conference Call May 20, 2025 9:00 AM ET Company Participants David Barnard - IR, Alliance Advisors Investor Relations Nate Bradley - Chief Executive Officer, Data Vault Holdings Conference Call Participants Jack Vander Aarde - Maxim Group Alfred Blair Blaikie III - Money Channel Operator Good day, and welcome to the Datavault AI Business Update Conference Call. All participants will be in listen-only mode.

NEW YORK CITY, NY / ACCESS Newswire / May 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Travere Therapeutics, Inc. ("Travere" or "the Company") (NASDAQ:TVTX). Investors who purchased Travere securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TVTX.

The quarterly 13F filing season is a goldmine for investors looking to uncover what some of the world's top hedge funds and institutional managers are buying and selling. Filed with the SEC within 45 days after each quarter's end, these disclosures provide a glimpse into the minds of elite investors managing more than $100 million, including big names like Warren Buffett, David Tepper, and Stanley Druckenmiller.

AGNC Investment Corp. yields nearly 16% after Q1 earnings due to a combination of price pullback and its latest payout declaration. However, I see a few signs of a dividend trap that I've learned from past experiences. Key AGNC red flags include declining EPS, an unsustainably high payout ratio, and shrinking tangible book value per share.

DALLAS , May 20, 2025 /PRNewswire/ -- Texas Instruments Incorporated (TI) (Nasdaq: TXN) today announced the pricing of two series of senior unsecured notes for an aggregate principal amount of $1.2 billion. The notes consist of the following: $550 million of 4.500% senior unsecured notes due May 23, 2030; and $650 million of 5.100% senior unsecured notes due May 23, 2035.

The DIV ETF pays a monthly dividend and is currently yielding a very attractive 7.85%. However, DIV's high yield masks long-term wealth destruction due to poor total returns and a declining share price. The fund's portfolio is filled with value traps and is overweight the underperforming energy sector, leading to severely lagging performance versus the broad market averages.

Google says it will commit up to $150 million to the consumer eyewear company Warby Parker to jointly develop AI-powered smart glasses based on Android XR, the companies said on Tuesday during Google I/O 2025.

Brixmor's defensive portfolio delivers stable, growing dividends with a proven track record of 4%+ annual growth and conservative leverage. Brixmor Property Group CEO James Taylor speaks to near term uncertainty and volatility.

NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Open Lending Corporation (NASDAQ: LPRO) between February 24, 2022 and March 31, 2025, both dates inclusive (the “Class Period”), of the June 30, 2025 lead plaintiff deadline.

PARSIPPANY, N.J. , May 20, 2025 /PRNewswire/ -- PBF Energy Inc. (NYSE:PBF) today announced that members of its management team will participate in the Goldman Sachs Tenth Annual Leveraged Finance Conference on May 28-29, 2025, and the Bank of America Energy and Power Credit Conference on June 4, 2025.

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=149453&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=149456&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=149457&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Digimarc Corporation (NASDAQ:DMRC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/digimarc-corporation-lawsuit-submission-form-2?prid=149455&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.